Conceptio › Archive › Europe PMC
Europe PMCopen access

Tebentafusp (IMCgp100), a first in class immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) for HLA-A*02:01 positive uveal melanoma: Product review

Cohen JE et al.
Europe PMC · Papers · License: Open Access
Open Source ↗Direct PDF ↓
Cancer Immunotherapy, Uveal Melanoma, T-cell Receptor (Tcr), Human Leukocyte Antigen (Hla), Immune-mobilizing Monoclonal T-cell Receptors Against Cancer (Immtac)
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 229690
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.